Clinical trial
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
NCT00004928 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004928 |
|---|---|
| Title | Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer |
| Official title | A Phase I Study of 1,25 Dihydroxy-Vitamin D3 (Calcitriol) in Patients With Prostate Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | calcitriol, zoledronic acid |
| Start date | Oct 1, 1999 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | May 14, 2003 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: